Drug Insights

Exploring cysteamine hydrochloride's Revolutionary R&D Successes and its Mechanism of Action on Drug Target

13 October 2023
4 min read

Cysteamine hydrochloride's R&D Progress

Cysteamine Hydrochloride is a small molecule drug that is primarily used to target the enzyme GSS (gamma-glutamylcysteine synthetase). This drug has been approved for use in the treatment of various therapeutic areas, including neoplasms, congenital disorders, digestive system disorders, endocrinology and metabolic disease, as well as skin and musculoskeletal diseases.

One of the active indications for Cysteamine Hydrochloride is cystinosis, a rare genetic disorder that affects the transport of cystine in the body. This drug has shown efficacy in reducing cystine accumulation in cells and has been approved for the treatment of cystinosis.

Additionally, Cysteamine Hydrochloride has also been approved for the treatment of gastrointestinal stromal tumors (GISTs). GISTs are a type of tumor that originates in the digestive tract, and this drug has demonstrated effectiveness in inhibiting the growth of these tumors.

After completing successful clinical trials and receiving regulatory approval, Cysteamine Hydrochloride has now reached its highest level of development and is approved for use. The drug, which was first approved in the United States in October 2012, has been designated as an orphan drug. This means that it is specifically meant to treat rare diseases or conditions that affect only a small number of patients.

👇Please click on the image below to directly access the latest data (R&D Status | Core Patent | Clinical Trial | Approval status in Global countries) of this drug.

Mechanism of Action for cysteamine hydrochloride: GSS stimulants

Glutathione S-transferase stimulants are substances or compounds that enhance the activity or production of glutathione S-transferase (GSS). GSS is an enzyme that plays a crucial role in detoxification processes within the body. It is involved in the conjugation of glutathione, a tripeptide composed of three amino acids, with various toxic substances, drugs, and metabolites, making them more water-soluble and easier to eliminate from the body.

From a biomedical perspective, GSS stimulants can refer to drugs or compounds that increase the expression or activity of GSS enzymes. These stimulants can potentially enhance the body's ability to detoxify harmful substances or drugs, leading to improved drug metabolism and elimination. They may be used in certain medical conditions where enhanced detoxification is desired, such as in cases of drug overdose or exposure to toxic chemicals.

It is important to note that the term "GSS stimulants" is not a widely recognized or established term in biomedicine. Therefore, it is advisable to consult scientific literature or medical professionals for specific information on any potential GSS stimulants and their applications. 

Drug Target R&D Trends for cysteamine hydrochloride

GSS, or Glutathione S-transferase, is an essential enzyme found in the human body that plays a crucial role in detoxification processes. It acts as a catalyst in the conjugation of glutathione with various harmful substances, such as toxins, drugs, and carcinogens, making them more water-soluble and easier to eliminate from the body. GSS also helps in the protection of cells against oxidative stress by neutralizing harmful free radicals. This enzyme is involved in maintaining cellular homeostasis and is vital for overall health and well-being. Understanding the role of GSS is important in developing strategies to enhance detoxification pathways and combat oxidative damage.

According to Patsnap Synapse, as of 12 Sep 2023, there are a total of 2 GSS drugs worldwide, from 6 organizations, covering 6 indications, and conducting 7 clinical trials.

Overall, the target GSS presents opportunities for further research and development, particularly in the areas of small molecule drugs and indications that are still in the inactive phase. Further analysis and monitoring of the competitive landscape and future developments in this target are recommended to stay updated on the latest advancements in the pharmaceutical industry.

👇Please click on the picture link below for free registration or log in directly if you have a freemium account, you can browse the latest research progress on drugs, indications, organizations, clinical trials, clinical results, and drug patents related to this target

Conclusion

In summary, Cysteamine Hydrochloride is a small molecule drug that targets the enzyme GSS. It has been approved for use in the treatment of various therapeutic areas, including cystinosis and gastrointestinal stromal tumors. The drug received its first approval in the United States in 2012 and is regulated as an orphan drug.

Decoding cyclizine hydrochloride: A Comprehensive Study of its R&D Trends and Mechanism on Drug Target
Drug Insights
4 min read
Decoding cyclizine hydrochloride: A Comprehensive Study of its R&D Trends and Mechanism on Drug Target
13 October 2023
This article summarized the latest R&D progress of cyclizine hydrochloride, the Mechanism of Action for cyclizine hydrochloride, and the drug target R&D trends for cyclizine hydrochloride.
Read →
Deep Scientific Insights on choline alfoscerate's R&D Progress, Mechanism of Action, and Drug Target
Drug Insights
4 min read
Deep Scientific Insights on choline alfoscerate's R&D Progress, Mechanism of Action, and Drug Target
13 October 2023
This article summarized the latest R&D progress of choline alfoscerate, the Mechanism of Action for choline alfoscerate, and the drug target R&D trends for choline alfoscerate.
Read →
An In-depth Analysis of cefroxadine's R&D Progress and Mechanism of Action on Drug Target
Drug Insights
5 min read
An In-depth Analysis of cefroxadine's R&D Progress and Mechanism of Action on Drug Target
13 October 2023
This article summarized the latest R&D progress of cefroxadine, the Mechanism of Action for cefroxadine, and the drug target R&D trends for cefroxadine.
Read →
 diclofenac diethylamine: Detailed Review of its Transformative R&D Success
Drug Insights
5 min read
diclofenac diethylamine: Detailed Review of its Transformative R&D Success
12 October 2023
This article summarized the latest R&D progress of diclofenac diethylamine, the Mechanism of Action for diclofenac diethylamine, and the drug target R&D trends for diclofenac diethylamine.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.